Search

everythinglearnresearchcommunity

for

Search:↓

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Female pattern hair loss does not significantly affect sexual dysfunction.

Bicalutamide may help treat female pattern hair loss.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

LLLT promotes hair growth and improves hair density safely in men and women.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Platelet Rich Plasma (PRP) injections can effectively reduce hair loss and improve hair growth in both men and women suffering from androgenic alopecia.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

There may be a link between hair loss and heart disease in women, but more research is needed.

Women with high androgen levels may have more severe COVID-19 symptoms.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Wigs greatly improve life quality for hair loss patients.

Hydroxychloroquine can help treat certain types of hair loss.